摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

camtothecin-20-O-methylthiomethyl ether

中文名称
——
中文别名
——
英文名称
camtothecin-20-O-methylthiomethyl ether
英文别名
(19S)-19-ethyl-19-(methylsulfanylmethoxy)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
camtothecin-20-O-methylthiomethyl ether化学式
CAS
——
化学式
C22H20N2O4S
mdl
——
分子量
408.478
InChiKey
DTUCSCKVNBVCRS-QFIPXVFZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    94
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    camtothecin-20-O-methylthiomethyl ether 以 phosphate buffer 、 二甲基亚砜 为溶剂, 反应 24.0h, 生成 (S)-2-(8-Hydroxymethyl-9-oxo-9,11-dihydro-indolizino[1,2-b]quinolin-7-yl)-2-methylsulfanylmethoxy-butyric acid
    参考文献:
    名称:
    20-O-Acylcamptothecin Derivatives:  Evidence for Lactone Stabilization
    摘要:
    Convincing UV and NMR spectrophotometric evidence is presented which demonstrates that at physiological pH, 7.4, 20-O-acyl derivatives of camptothecin (CPT) are substantially more stable in the lactone form than the 20-OH parent. Additionally, it was determined by HPLC analysis that the lactone ring of a 20-O-ether derivative of CPT underwent endocyclic ring opening at pR greater than or equal to 8.5, while the lactone ring of 20-O-acyl CPT derivatives remained unaffected. PEG (and other smaller alkyl) 20-O-acyl-CPT derivatives released native CPT at pH > 9.5, which arises from exocyclic cleavage, thus precluding isolation of any open CPT acyl PEG (or alkyl) carboxylate forms.
    DOI:
    10.1021/jo000221n
  • 作为产物:
    描述:
    二甲基亚砜喜树碱乙酸酐 为溶剂, 反应 48.0h, 以83%的产率得到camtothecin-20-O-methylthiomethyl ether
    参考文献:
    名称:
    20-O-Acylcamptothecin Derivatives:  Evidence for Lactone Stabilization
    摘要:
    Convincing UV and NMR spectrophotometric evidence is presented which demonstrates that at physiological pH, 7.4, 20-O-acyl derivatives of camptothecin (CPT) are substantially more stable in the lactone form than the 20-OH parent. Additionally, it was determined by HPLC analysis that the lactone ring of a 20-O-ether derivative of CPT underwent endocyclic ring opening at pR greater than or equal to 8.5, while the lactone ring of 20-O-acyl CPT derivatives remained unaffected. PEG (and other smaller alkyl) 20-O-acyl-CPT derivatives released native CPT at pH > 9.5, which arises from exocyclic cleavage, thus precluding isolation of any open CPT acyl PEG (or alkyl) carboxylate forms.
    DOI:
    10.1021/jo000221n
点击查看最新优质反应信息

文献信息

  • [EN] WATER SOLUBLE PRODRUGS OF HINDERED ALCOHOLS OR PHENOLS<br/>[FR] PROMÉDICAMENTS SOLUBLES DANS L'EAU À FONCTION ALCOOL OU PHENOL MASQUÉ
    申请人:UNIV KANSAS
    公开号:WO2000008033A1
    公开(公告)日:2000-02-17
    The present invention is directed to novel water-soluble prodrugs of aliphatic or aromatic hindered hydroxyl group containing pharmaceuticals.
    本发明涉及一种新型水溶性脂肪族或芳香族受阻羟基含药物的前药。
  • Water soluble prodrugs of hindered alcohols or phenols
    申请人:THE UNIVERSITY OF KANSAS
    公开号:EP1683803A1
    公开(公告)日:2006-07-26
    The present invention is directed to novel water-soluble prodrugs of aliphatic or aromatic hindered hydroxyl group containing pharmaceuticals.
    本发明涉及含脂肪族或芳香族受阻羟基药物的新型水溶性原药。
  • Water soluble prodrugs of hindered alcohols
    申请人:University of Kansas
    公开号:US20010025035A1
    公开(公告)日:2001-09-27
    The present invention is directed to novel water-soluble prodrugs of aliphatic or aromatic hindered hydroxyl group containing pharmaceuticals.
    本发明涉及含脂肪族或芳香族受阻羟基药物的新型水溶性原药。
  • WATER SOLUBLE PRODRUGS OF HINDERED PHENOLS
    申请人:THE UNIVERSITY OF KANSAS
    公开号:EP1102776B1
    公开(公告)日:2006-03-08
  • WATER SOLUBLE PRODRUGS OF HINDERED ALCOHOLS OR PHENOLS
    申请人:THE UNIVERSITY OF KANSAS
    公开号:EP1102776A1
    公开(公告)日:2001-05-30
查看更多

同类化合物

鲁比替康 羧基喜树碱 盐酸拓扑替康 盐酸希明替康 盐酸伊立替康 拓扑替康-d6羧酸钠盐 拓扑替康-d5 拓扑替康 托泊替康醋酸盐; 醋酸拓扑替康; 4-乙基-4,9-二羟基-10-[(二甲基氨基)甲基]-1H-吡喃并[3',4':6,7]中氮茚并[1,2-b]喹啉-3,14(4H,12H)-二酮醋酸盐 戈维替康-沙西妥珠单抗 戈维替康-拉贝妥珠单抗 喜树碱钠盐 喜树碱杂质16 喜树碱 吉马替康 勒托替康 依喜替康甲磺酸盐 依喜替康 伊立替康杂质3 伊立替康 他克莫司 SN-38三-O-乙酰基-beta-D-葡萄糖醛酸甲酯 O-乙酰基喜树碱 N-去甲拓扑替康 N-去甲基拓扑替康-d3 9-羟基甲基-10-羟基喜树碱 9-硝基喜树碱 9-硝基-(20RS)-喜树碱 9-甲氧基喜树碱 9-甲氧基喜树碱 9-氮-10-羟基喜树碱 9-氨基喜树碱 8-乙基伊立替康 7-甲氧基甲基喜树碱 7-甲氧基喜树碱 7-甲基喜树碱 7-甲基-10-溴乙酰氨基甲基喜树碱 7-乙氧基甲基喜树碱 7-乙基喜树碱1-氧化物 7-乙基喜树碱 7-乙基-10-羟基喜树碱-D3 7-乙基-10-羟基喜树碱 7-乙基-10-(4-N-氨基戊酸)-1-哌啶)羰基氧基喜树碱盐酸盐 7,11-二乙基-10-羟基喜树碱 5-{[1-({[(4S)-4,11-二乙基-4-羟基-3,14-二氧代-3,4,12,14-四氢-1H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-9-基]氧基}羰基)-4-哌啶基]氨基}戊酸 4-乙基-4-羟基-3,4,12,14-四氢-1H-吡喃并[3'4':6,7]吲哚嗪并[1,2-b]喹啉-3,14-二酮 4,11-二乙基-4,9-二羟基-1H-吡喃并[3’,4’:6,7]中氮茚并[1,2-B]喹啉-3,14(4H,12H)-二酮 4,11-二乙基-4,9-二羟基-1H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-3,14(4H,12H)-二酮 20R-喜树碱 2-(氨甲基)苯乙酸盐酸盐